share_log

Cantor Fitzgerald Reiterates Overweight on Harmony Biosciences, Maintains $49 Price Target

Moomoo 24/7 ·  Apr 12 09:53

Cantor Fitzgerald analyst Charles Duncan reiterates Harmony Biosciences (NASDAQ:HRMY) with a Overweight and maintains $49 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment